Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease".

Pauwels RWM, de Vries AC, van der Woude CJ.

Inflamm Bowel Dis. 2019 Apr 11;25(5):e59. doi: 10.1093/ibd/izy273. No abstract available.

PMID:
31222304
2.

Ustekinumab for Crohn's disease: results of the ICC Registry, a nationwide prospective observational cohort study.

Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Löwenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F; Dutch Initiative on Crohn and Colitis (ICC).

J Crohns Colitis. 2019 Jun 14. pii: jjz119. doi: 10.1093/ecco-jcc/jjz119. [Epub ahead of print]

PMID:
31219157
3.

Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn's disease perianal fistulas.

Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE.

J Crohns Colitis. 2019 Jun 14. pii: jjz116. doi: 10.1093/ecco-jcc/jjz116. [Epub ahead of print]

PMID:
31197361
4.

Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease: A Nationwide Cohort Study.

Beelen EMJ, van der Woude CJ, Pierik MJ, Hoentjen F, de Boer NK, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Dijkstra G, Bruggink AH, Erler NS, Schouten WR, de Vries AC; Dutch Initiative on Crohnʼs and Colitis (ICC).

Ann Surg. 2019 Jun 10. doi: 10.1097/SLA.0000000000003395. [Epub ahead of print]

PMID:
31188225
5.

Modulation of cytokine patterns and microbiome during pregnancy in IBD.

van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, Louzoun Y, Peppelenbosch MP, van der Woude CJ, Koren O, Fuhler GM.

Gut. 2019 Jun 5. pii: gutjnl-2019-318263. doi: 10.1136/gutjnl-2019-318263. [Epub ahead of print]

6.

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.

Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D'Haens G, Vermeire S, Gils A.

Clin Gastroenterol Hepatol. 2019 May 22. pii: S1542-3565(19)30551-8. doi: 10.1016/j.cgh.2019.05.029. [Epub ahead of print]

PMID:
31128336
7.

Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.

van den Brink G, Stapersma L, Bom AS, Rizopolous D, van der Woude CJ, Stuyt RJL, Hendriks DM, van der Burg JAT, Beukers R, Korpershoek TA, Theuns-Valks SDM, Utens EMWJ, Escher JC.

Inflamm Bowel Dis. 2019 May 3. pii: izz073. doi: 10.1093/ibd/izz073. [Epub ahead of print]

PMID:
31050763
8.

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.

Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC).

Aliment Pharmacol Ther. 2019 May;49(10):1293-1300. doi: 10.1111/apt.15229. Epub 2019 Mar 25.

PMID:
30908719
9.

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease.

van der Giessen J, Huang VW, van der Woude CJ, Fuhler GM.

Clin Transl Gastroenterol. 2019 Mar;10(3):e00009. doi: 10.14309/ctg.0000000000000009.

10.

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models.

van der Giessen J, van der Woude CJ, Peppelenbosch MP, Fuhler GM.

Cells. 2019 Mar 19;8(3). pii: E261. doi: 10.3390/cells8030261.

11.

Pregnancy, psychiatry and IBD: multidisciplinary care is crucial.

van der Woude CJ, Shitrit AB.

Nat Rev Gastroenterol Hepatol. 2019 May;16(5):265-266. doi: 10.1038/s41575-019-0135-9. No abstract available.

PMID:
30890814
12.

Epithelial endoplasmic reticulum stress orchestrates a protective IgA response.

Grootjans J, Krupka N, Hosomi S, Matute JD, Hanley T, Saveljeva S, Gensollen T, Heijmans J, Li H, Limenitakis JP, Ganal-Vonarburg SC, Suo S, Luoma AM, Shimodaira Y, Duan J, Shih DQ, Conner ME, Glickman JN, Fuhler GM, Palm NW, de Zoete MR, van der Woude CJ, Yuan GC, Wucherpfennig KW, Targan SR, Rosenstiel P, Flavell RA, McCoy KD, Macpherson AJ, Kaser A, Blumberg RS.

Science. 2019 Mar 1;363(6430):993-998. doi: 10.1126/science.aat7186.

PMID:
30819965
13.

Health Care Transition Outcomes in Inflammatory Bowel Disease: a Multinational Delphi Study.

van den Brink G, van Gaalen MAC, de Ridder L, van der Woude CJ, Escher JC.

J Crohns Colitis. 2019 Feb 14. pii: jjz044. doi: 10.1093/ecco-jcc/jjz044. [Epub ahead of print]

PMID:
30766997
14.

Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.

Goetgebuer RL, van der Woude CJ, de Ridder L, Doukas M, de Vries AC.

Int J Colorectal Dis. 2019 May;34(5):923-926. doi: 10.1007/s00384-019-03257-7. Epub 2019 Feb 9.

PMID:
30739187
15.

Fatigue in IBD: epidemiology, pathophysiology and management.

Borren NZ, van der Woude CJ, Ananthakrishnan AN.

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):247-259. doi: 10.1038/s41575-018-0091-9. Review.

PMID:
30531816
16.

Cholecystectomy Risk in Crohn's Disease Patients After Ileal Resection: a Long-term Nationwide Cohort Study.

Goet JC, Beelen EMJ, Biermann KE, Gijsbers AH, Schouten WR, van der Woude CJ, de Vries AC.

J Gastrointest Surg. 2018 Nov 8. doi: 10.1007/s11605-018-4028-y. [Epub ahead of print]

PMID:
30411310
17.

Editorial: The Effect of Thiopurines on Offspring.

Wieringa JW, van der Woude CJ.

J Crohns Colitis. 2019 Jan 1;13(1):1-2. doi: 10.1093/ecco-jcc/jjy134. No abstract available.

PMID:
30272119
18.

Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system.

Wieringa JW, Driessen GJ, Van Der Woude CJ.

Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):811-818. doi: 10.1080/17474124.2018.1496820. Epub 2018 Jul 12. Review.

PMID:
29972674
19.

Self-efficacy did not predict the outcome of the transition to adult care in adolescents with inflammatory bowel disease.

van den Brink G, van Gaalen MAC, Zijlstra M, de Ridder L, van der Woude CJ, Escher JC.

Acta Paediatr. 2019 Feb;108(2):333-338. doi: 10.1111/apa.14471. Epub 2018 Jul 10.

PMID:
29926962
20.

TNF-α exerts potent anti-rotavirus effects via the activation of classical NF-κB pathway.

Hakim MS, Ding S, Chen S, Yin Y, Su J, van der Woude CJ, Fuhler GM, Peppelenbosch MP, Pan Q, Wang W.

Virus Res. 2018 Jul 15;253:28-37. doi: 10.1016/j.virusres.2018.05.022. Epub 2018 May 31.

21.

Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type.

Kanis SL, de Lima-Karagiannis A, van der Ent C, Rizopoulos D, van der Woude CJ.

J Crohns Colitis. 2018 Jul 30;12(8):939-947. doi: 10.1093/ecco-jcc/jjy058.

PMID:
29771301
22.

Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero.

de Lima A, Kanis SL, Escher JC, van der Woude CJ.

J Crohns Colitis. 2018 Jul 30;12(8):948-953. doi: 10.1093/ecco-jcc/jjy053.

PMID:
29726943
23.

Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.

Ten Hove JR, Shah SC, Shaffer SR, Bernstein CN, Castaneda D, Palmela C, Mooiweer E, Elman J, Kumar A, Glass J, Axelrad J, Ullman TA, Colombel JF, Torres J, van Bodegraven AA, Hoentjen F, Jansen JM, de Jong ME, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Itzkowitz SH, Oldenburg B.

Gut. 2019 Apr;68(4):615-622. doi: 10.1136/gutjnl-2017-315440. Epub 2018 May 2.

PMID:
29720408
24.

Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.

Meijer B, Mulder CJJ, Bouma G, Ponsioen CY, van der Woude CJ, van der Meulen AE, Wintjens DSJ, Dijkstra G, Hoentjen F, Oldenburg B, van Bodegraven AA, de Boer NKH; Dutch Initiative on Crohn and Colitis (ICC) and Parelsnoer Institute.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1558-1565. doi: 10.1093/ibd/izy047.

PMID:
29668998
25.

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

Lie MRKL, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ.

J Transl Med. 2018 Mar 9;16(1):55. doi: 10.1186/s12967-018-1427-5.

26.

Correlating Fecal Calprotectin With Hemoglobin Levels Within 1 Sample.

Fuhler GM, van der Giessen J, van der Woude CJ, Peppelenbosch MP.

Inflamm Bowel Dis. 2018 Feb 15;24(3):663. doi: 10.1093/ibd/izx028. No abstract available.

PMID:
29462378
27.

High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.

Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1106-1113.e3. doi: 10.1016/j.cgh.2018.01.023. Epub 2018 Mar 15.

PMID:
29378311
28.

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Visschedijk MC, Spekhorst LM, Cheng SC, van Loo ES, Jansen BHD, Blokzijl T, Kil H, de Jong DJ, Pierik M, Maljaars JPWJ, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Nieuwenhuijs VB, Imhann F, van Sommeren S, Alberts R, Xavier RJ, Dijkstra G, Nico Faber K, Aldaz CM, Weersma RK, Festen EAM.

J Crohns Colitis. 2018 Apr 27;12(5):582-588. doi: 10.1093/ecco-jcc/jjy001.

PMID:
29361163
29.

Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease.

Kreijne JE, van der Giessen J, Verhaar AP, Peppelenbosch MP, de Vries AC, van der Woude CJ, Fuhler GM.

J Clin Gastroenterol. 2019 May/Jun;53(5):395-397. doi: 10.1097/MCG.0000000000000952. No abstract available.

PMID:
29256991
30.

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease.

Nuij VJAA, Peppelenbosch MP, van der Woude CJ, Fuhler GM.

J Transl Med. 2017 Dec 11;15(1):248. doi: 10.1186/s12967-017-1355-9.

31.

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus.

Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP.

J Crohns Colitis. 2018 Mar 28;12(4):408-418. doi: 10.1093/ecco-jcc/jjx161.

PMID:
29216349
32.

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease.

Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, d'Haens G, Hoentjen F, Hommes DW, de Jong DJ, Löwenberg M, Maljaars PWJ, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, Ponsioen CY, Stokkers PC, Verspaget HW, Visschedijk MC, van der Woude CJ, Dijkstra G, Weersma RK; Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC).

BMJ Open. 2017 Nov 8;7(11):e016695. doi: 10.1136/bmjopen-2017-016695.

33.

The Impact of Ethnicity and Country of Birth on Inflammatory Bowel Disease Phenotype: a Prospective Cohort Study.

Spekhorst LM, Severs M, de Boer NKH, Festen EAM, Fidder HH, Hoentjen F, Imhann F, de Jong DJ, van der Meulen-de Jong AE, Pierik MJ, van der Woude CJ, Dijkstra G, Ponsioen CY, Löwenberg M, Oldenburg B, Weersma RK; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2017 Dec 4;11(12):1463-1470. doi: 10.1093/ecco-jcc/jjx098.

PMID:
28981621
34.

Analysis of SHIP1 expression and activity in Crohn's disease patients.

Somasundaram R, Fernandes S, Deuring JJ, de Haar C, Kuipers EJ, Vogelaar L, Middleton FA, van der Woude CJ, Peppelenbosch MP, Kerr WG, Fuhler GM.

PLoS One. 2017 Aug 2;12(8):e0182308. doi: 10.1371/journal.pone.0182308. eCollection 2017.

35.

Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.

Eppinga H, Poortinga S, Thio HB, Nijsten TEC, Nuij VJAA, van der Woude CJ, Vodegel RM, Fuhler GM, Peppelenbosch MP.

Inflamm Bowel Dis. 2017 Oct;23(10):1783-1789. doi: 10.1097/MIB.0000000000001169.

PMID:
28617755
36.

Endoscopy for Inflammatory Bowel Disease During Pregnancy: Only When There Is a Strong Indication.

Kanis SL, van der Woude CJ.

Gastroenterology. 2017 Jul;153(1):330-331. doi: 10.1053/j.gastro.2016.12.054. Epub 2017 Jun 1. No abstract available.

PMID:
28579272
37.

Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters.

Vogelaar L, de Haar C, Aerts BR, Peppelenbosch MP, Timman R, Hanssen BE, van der Woude CJ.

Clin Exp Gastroenterol. 2017 May 2;10:83-90. doi: 10.2147/CEG.S123942. eCollection 2017.

38.

Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.

Kanis SL, de Lima-Karagiannis A, de Boer NKH, van der Woude CJ.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1232-1241.e1. doi: 10.1016/j.cgh.2017.02.041. Epub 2017 Mar 22.

PMID:
28342949
39.

Commentary on " Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: A systematic review with meta-analysis".

Kanis SL, Kreijne JE, van der Woude CJ.

Hum Exp Toxicol. 2017 Sep;36(9):993-994. doi: 10.1177/0960327116689719. Epub 2017 Jan 23. No abstract available.

PMID:
28111975
40.

Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease.

Lie MR, Kreijne JE, van der Woude CJ.

Inflamm Bowel Dis. 2017 Jan;23(1):75-81. doi: 10.1097/MIB.0000000000000981.

PMID:
28002127
41.

6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients.

Meijer B, Kreijne JE, van Moorsel SAW, Derijks LJJ, Bouma G, Mulder CJJ, Wong DR, van der Woude CJ, van Bodegraven AA, de Boer NKH.

J Gastroenterol Hepatol. 2017 Jun;32(6):1183-1190. doi: 10.1111/jgh.13656.

PMID:
27859568
42.

An unexpected cause of terminal ileitis.

Harinck F, van Putten PG, Kreijne JE, Bruno MJ, van der Woude CJ, de Vries AC.

Gastrointest Endosc. 2017 Feb;85(2):453. doi: 10.1016/j.gie.2016.10.001. Epub 2016 Oct 8. No abstract available.

PMID:
27729214
43.

Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.

Hoekstra E, Das AM, Willemsen M, Swets M, Kuppen PJ, van der Woude CJ, Bruno MJ, Shah JP, Ten Hagen TL, Chisholm JD, Kerr WG, Peppelenbosch MP, Fuhler GM.

Oncotarget. 2016 Nov 8;7(45):73525-73540. doi: 10.18632/oncotarget.12321.

44.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollón F; ECCO.

J Crohns Colitis. 2017 Feb;11(2):135-149. doi: 10.1093/ecco-jcc/jjw169. Epub 2016 Sep 22.

PMID:
27660342
45.

Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.

Severs M, Mangen MJ, van der Valk ME, Fidder HH, Dijkstra G, van der Have M, van Bodegraven AA, de Jong DJ, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, van de Meeberg PC, Mahmmod N, Ponsioen CY, Vermeijden JR, van der Meulen-de Jong AE, Pierik M, Siersema PD, Oldenburg B; COIN study group and the Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2017 Mar 1;11(3):342-352. doi: 10.1093/ecco-jcc/jjw160.

PMID:
27647859
46.

[Transition from paediatric to adult care: management of adolescents with inflammatory bowel disease].

van den Brink G, van der Woude CJ, de Ridder L, van Gaalen MA, Escher JC.

Ned Tijdschr Geneeskd. 2016;160:D578. Dutch.

PMID:
27581867
47.

Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy.

Kanis SL, van der Woude CJ.

Dig Dis. 2016;34 Suppl 1:61-6. doi: 10.1159/000447377. Epub 2016 Aug 22.

48.

Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2.

Visschedijk MC, Alberts R, Mucha S, Deelen P, de Jong DJ, Pierik M, Spekhorst LM, Imhann F, van der Meulen-de Jong AE, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Dijkstra G, Ellinghaus D, Schreiber S, Wijmenga C; Initiative on Crohn and Colitis; Parelsnoer Institute, Rivas MA, Franke A, van Diemen CC, Weersma RK.

PLoS One. 2016 Aug 4;11(8):e0159609. doi: 10.1371/journal.pone.0159609. eCollection 2016.

49.

The ATG16L1 risk allele associated with Crohn's disease results in a Rac1-dependent defect in dendritic cell migration that is corrected by thiopurines.

Wildenberg ME, Koelink PJ, Diederen K, Te Velde AA, Wolfkamp SC, Nuij VJ, Peppelenbosch MP, Nobis M, Sansom OJ, Anderson KI, van der Woude CJ, D'Haens GR, van den Brink GR.

Mucosal Immunol. 2017 Mar;10(2):352-360. doi: 10.1038/mi.2016.65. Epub 2016 Jul 20.

PMID:
27435106
50.

The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.

de Lima-Karagiannis A, Zelinkova-Detkova Z, van der Woude CJ.

Am J Gastroenterol. 2016 Sep;111(9):1305-12. doi: 10.1038/ajg.2016.254. Epub 2016 Jun 28.

PMID:
27349339

Supplemental Content

Loading ...
Support Center